Reported 1 day ago
Bausch + Lomb is exploring potential sale options alongside other strategies to facilitate its Canadian parent company, Bausch Health, exit from the eye-care business. This announcement follows media speculation and volatility in the company's shares, amid reports of a joint bid by private equity firms TPG and Blackstone that could value the company at up to $11.5 billion.
Source: YAHOO